glycerol phenylbutyrate

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Urea cycle disorders

Manufacturer:

Horizon Therapeutics Canada/Horizon Pharma Ireland Ltd.

Call for patient/clinician input open:

August 2, 2016

Brand Name:

Ravicti

Project Line:

Reimbursement Review

Project Number:

SR0497-000

Call for patient/clinician input closed:

September 21, 2016

NOC Status at Filing:

Post NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Urea cycle disorders

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

March 21, 2017

Last Updated : August 2, 2016